study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
Published 5 years ago • 3K plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
4:14
study of gdc-0084 with trastuzumab in her2-positive breast cancer with brain metastases
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
2:25
what is her2-positive breast cancer? | dana-farber cancer institute
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
3:51
study comparing margetuximab combinations to trastuzumab combinations in her2-positive breast cancer
-
4:59
study of saci-io for hormone receptor positive metastatic breast cancer
-
1:36
is her2-low a distinct subtype of breast cancer?
-
2:33
breast cancer: young mother embraces life | dana-farber cancer institute
-
6:08
first-line treatment of her2-positive metastatic breast cancer
-
2:43
study of ds-8201a in her2-low, unresectable and/or metastatic breast cancer
-
1:29
poziotinib for her2-positive metastatic breast cancer
-
2:13
remaining questions surrounding her2-low breast cancer – how low can you go?
-
1:45
asco23: sara tolaney, md, mph | dana-farber cancer institute
-
23:52
breast cancer and the immune system at mbc patient forum 2019
-
0:59
treatment for early stage her2 breast cancer | dana-farber cancer institute
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute